BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2324883)

  • 1. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
    Dubois RS; Rodgerson DO; Hambidge KM
    J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
    Walshe JM
    Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy].
    Ishitsu T; Chikazawa S
    No To Hattatsu; 1989 May; 21(3):294-6. PubMed ID: 2736129
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH; Jaffe ME; Sternlieb I
    N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triethylene-tetramine (trien) therapy for Wilson's disease.
    Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
    Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
    Williams FJ; Walshe JM
    Brain; 1981 Dec; 104(Pt 4):735-52. PubMed ID: 7326565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case.
    Watson RG
    Ulster Med J; 1983; 52(1):48-53. PubMed ID: 6687321
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of trientine therapy in Wilson's disease with neurological symptoms].
    Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
    No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease, an end to the search for new therapy?
    May PM; Jones DC; Williams DR
    Lancet; 1982 May; 1(8281):1127. PubMed ID: 6122924
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease.
    Asatoor AM; Milne MD; Walshe JM
    J R Coll Physicians Lond; 1983 Apr; 17(2):122-5. PubMed ID: 6842414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triethylene tetramine in Wilson's disease].
    Rave D; Vengrover D; Kleinman J; Leitersdorf E
    Harefuah; 1986 Feb; 110(4):178-9. PubMed ID: 3721331
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Wilson's disease: penicillamine or triene?
    Kiechl SG; Willeit J; Aichner F; Felber S
    Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992
    [No Abstract]   [Full Text] [Related]  

  • 20. Trientine for Wilson's disease.
    Med Lett Drugs Ther; 1986 Jul; 28(717):67. PubMed ID: 3724656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.